Key result
RA233 is a powerful inhibitor of platelet function in vitro, significantly more potent than its analogue RA433 in some systems.
RA233 demonstrates potent in vitro inhibition of multiple platelet functions, including aggregation and clot retraction, outperforming its analogue RA433 in some assays.
No takes yet. Share an insight, caveat, or question.
Supports pursuit of RA233 for antiplatelet therapy; leaves open whether in vitro potency predicts clinical benefit.
Hassanein et al. (1970) studied this question. RA233 vs. RA433 was evaluated on Platelet function (aggregation, retention, factor 3 release, clot retraction). RA233 is a powerful inhibitor of platelet function in vitro, significantly more potent than its analogue RA433 in some systems.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: